Research only
All of alz.org
ALZ.ORG Research Center Alzheimer's Association International Conference ISTAART Journal Grants TrialMatch Press Donate Contact

Scientific Sessions

The schedule below reflects the invited program only. The complete schedule, including the submitted program, will be posted online in May.

Code
Time
SUNDAY, JULY 19, 2015
S1-01
8-9:30 a.m
Symposium Session
The Blood Brain Barrier In Alzheimer’s Disease
S1-01-01
8-8:20 a.m.
Blood Brain Barrier From Physiology To Therapeutics William Pardridge
University of California, Los Angeles
S1-01-02
8:20-8:40 a.m.
Biotherapeutics And The Blood Brain Barrier Berislav Zlokovic
University of California, Los Angeles
S1-01-03
8:40-9 a.m.
Perivascular Clearance Of Amyloid-beta Roxana Carare
University of Southampton
S1-01-04
9-9:20 a.m.
Vascular Contributions To Cognitive Impairment Sudha Seshadri
Boston University School of Medicine
PL-01
10:30-11:30 a.m. Plenary Session
PL-01-02
10:30-11 a.m.
Association Welcome
Will include the Opening Ceremony and Presentation of the AAIC Lifetime Achievement Awards:
• Khalid Iqbal Lifetime Achievement Award
• Bengt Winblad Lifetime Achievement Awards
• Henry Wisniewski Lifetime Achievement Award
PL-01-02
11-11:30 a.m.
What Will It Take To End Alzheimer's? Eric Reiman
Banner Alzheimer’s Institute

 

 

Code
Time
MONDAY, JULY 20, 2015
S2-01
8-9:30 a.m
Symposium Session
Novel Approaches in Methods for Dementia Epidemiology
S2-01-01
8-8:20 a.m.
Epigenetic Considerations In Cognitive Decline Riccardo Marioni
University of Edinburgh
S2-01-02
8:20-8:40 a.m.
Methods To Account Forr Attrition Due To Death In Dementia Cohort Studies Eric Tchetgen Tchetgen
Harvard School of Public Health
S2-01-03
8:40-9 a.m.
Analytic Challenges And Potential Solutions In Cognitive Decline And Dementia Research: The Melodem Initiative: Carole Dufouil
INSERM U897
S2-01-04
9-9:20 a.m.
Methodological Considerations For Dementia In 90+ Maria Corrada-Bravio
University of California, Irvine
S2-02
8-9:30 a.m
Symposium Session
The Biology Associated with Genetic Abnormalities
S2-02-01
8-8:20 a.m.
TREM2 Jason Ulrich
Washington Univeristy in St. Louis
S2-02-02
8:20-8:40 a.m.
Genetic Risk Factors Of Alzheimer's Disease And APP Metabolism Jean-Charles Lambert
Institut Pasteur de Lille
S2-02-03
8:40-9 a.m.
Lessons From Multiple Sclerosis Philip De Jager
Brigham and Women's Hospital, Harvard Medical School
S2-02-04
9-9:20 a.m.
Phospholipase D3 Contributes to Alzheimer’s Disease Risk Via Disruption in APP Trafficking and Aβ Generation Celeste Karch
Washington Univeristy in St. Louis
PL-02
10:30-11:30 a.m. Plenary Session
PL-02-01
10:30-11 a.m.
Behavioral Interventions For Psychosocial Care Laura Gitlin
Johns Hopkins School of Nursing
PL-02-02
11-11:30 a.m.
Frontotemporal Dementia: A Quarter Century Of Progress Bruce Miller
University of California, San Francisco

 

 

Code
Time
TUESDAY, JULY 21, 2015
S3-01
8-9:30 a.m
Symposium Session
Re-evaluation of Modifiable Lifestyle Factors in Prevention
S3-01-01
8-8:20 a.m.
Prevention Report From Alzheimer's Disease International (ADI) Martin Prince
King’s College London
S3-01-02
8:20-8:40 a.m.
Is There a Need For Larger Prevention Trials? Laura Fratiglioni
Karolinska Institutet
S3-01-03
8:40-9 a.m.
Experiential And Psychosocial Risk Factors For Dementia David Bennett
Rush University Medical Center
S3-01-04
9-9:20 a.m.
Is It Time To Go Beyond Randomized Controlled Trials? Kaarin Anstey
The Australian National University
S3-02
8-9:30 a.m
Symposium Session
Novel Trial Design
S3-02-01
8-8:20 a.m.
Quantifying The Placebo Effect Through Quantitative Pharmacology Klaus Romero
Critical Path Institute
S3-02-02
8:20-8:40 a.m.
Prevention Trials Craig Ritchie
University of Edinburgh
S3-02-03
8:40-9 a.m.
Trial Design Lon Schneideri
University of Southern California
S3-02-04
9-9:20 a.m.
Ethics in Alzheimer's Disease Prevention Clinical Trial Design Joshua Grill
University of California, Irvine
PL-03
10:30-11:30 a.m. Plenary Session
PL-03-01
10:30-11 a.m.
Microinfarcts: Key To Prevention Of The Vascular Burden In Dementia? Geert Jan Biessels
University Medical Center Utrecht Brain Center Rudolf Magnus
PL-03-02
11-11:30 a.m.
Inge Grundke-Iqbal Lecture for Alzheimer’s Research: To be announced.
(This lecture recognizes the senior author of the most impactful study on the biology of Alzheimer’s disease and related conditions published during the two calendar years preceding AAIC.)
To be announced.

 

 

Code
Time
WEDNESDAY, JULY 22, 2015
S4-01
8-9:30 a.m
Symposium Session
Models of Alzheimer’s Disease: Insights From the Oldest Old
S4-01-01
8-8:20 a.m.
Supercentenarians Pathology Henne Holstege
VU Medical Center Amsterdam
S4-01-02
8:20-8:40 a.m.
The 90+ Study Claudia Kawas
University of California, Irvine
S4-01-03
8:40-9 a.m.
Neurobiologic Features Of Cognitive SuperAging Emily Rogalski
Northwestern University
S4-01-04
9-9:20 a.m.
Amyloid Imaging in the 80+ and Cognitive Trajectories (GEMS) Oscar Lopez
University of Pittsburgh
S4-02
8-9:30 a.m
Symposium Session
Current Status of Transmissibility
S4-02-01
8-8:20 a.m.
Cell To Cell Transmission Of Tauopathy Karen Duff
Columbia University
S4-02-02
8:20-8:40 a.m.
Modeling Braak-like Progression Of Tangle In The Medial Temporal Lobe Brad Hyman
Massachusetts General Hospital
S4-02-03
8:40-9 a.m.
Cell to Cell Transmission Of Synucleinopathy Benoit Giassoni
University of Florida
S4-02-04
9-9:20 a.m.
Abeta Transmissiblity Mathias Jucker
German Center for Neurodegenerative Diseases
PL-04
10:30-11:30 a.m. Plenary Session
PL-04-01
10:30-11 a.m.
Advances In Genetics Alison Goate
Icahn School of Medicine at Mount Sinai
PL-04-02
11-11:30 a.m.
Biochemically Based Quantitative Neuropathology In The Clinical Cohorts Thomas Montine
University of Washington

 

 

Code
Time
THURSDAY, JULY 23, 2015
S5-01
8:30-10 a.m
Symposium Session
Novel Developments in Fluid Biomarkers
S5-01-01
8:30-8:50 a.m.
Biomarkers of Synaptic Integrity In CSF Anne Fagan
Washington University in St. Louis
S5-01-02
8:50-9:10 a.m.
Blood Biomarker Assays Sid O'Bryant
University of North Texas Health Science Center
S5-01-03
9:10-9:30 a.m.
CSF Biomarkers vs PET Biomarkers Niklas Mattsson
Lund University
S5-01-04
9:30-9:50 a.m.
AlzBiomarker Database On Established And Novel CSF And Plasma Biomarkers For Alzheimer’s Disease Bob Olsson
University of Gothenburg
PL-05
10:30-11:30 a.m. Plenary Session
PL-05-01
10:30-11 a.m.
Clinical And Research Utility Of Alzheimer Biomarkers John Morris
Washington University in St. Louis
PL-05-02
11-11:30 a.m.
Open Challenges: Real Time Data, Novel Ways To Understand Dementia Stephen Friend
Sage Bionetworks

Submit your Developing Topic abstract

Developing Topic submissions are now open. Share your latest research with AAIC attendees. Submit your abstract now. The submission deadline is May 4, 2015.

 


Where the world reveals the latest dementia research • Washington, D.C., United States • July 18-23, 2015